New hope for Tough-to-Treat cancers: experimental drug trial opens
NCT ID NCT05101070
Summary
This study is testing a new drug called S-531011 for people with advanced solid tumors that have spread or cannot be removed by surgery. The main goals are to find a safe dose and see if the drug, given alone or with other cancer therapies, can shrink tumors. It is for adults who have run out of standard treatment options.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SOLID TUMORS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Angeles Clinic and Research Center
ACTIVE_NOT_RECRUITINGLos Angeles, California, 90025, United States
-
Fox Chase Cancer Center
RECRUITINGPhiladelphia, Pennsylvania, 19111, United States
-
Henry Ford Health Center
ACTIVE_NOT_RECRUITINGDetroit, Michigan, 48202, United States
-
MD Anderson Cancer Center
RECRUITINGHouston, Texas, 77030, United States
-
National Cancer Center Hospital
RECRUITINGChuo Ku, Tokyo, Japan
-
National Cancer Center Hospital East
RECRUITINGKashiwa, Chiba, Japan
-
The University of Osaka Hospital
RECRUITINGSuita, Osaka, Japan
-
University of Florida Health
RECRUITINGGainesville, Florida, 32610, United States
Conditions
Explore the condition pages connected to this study.